Background Background Major depressive
Major depressive disorder is the second leading cause of disorder is the second leading cause of disability-adjusted life-years in developed disability-adjusted life-years in developed regions of the world and antidepressants regions of the world and antidepressants are the third-ranking therapy class are the third-ranking therapy class worldwide. worldwide.
Aims Aims To testthe public health impact of
To testthe public health impact of the escalating sales of antidepressants. the escalating sales of antidepressants.
Method Method Nationwide data from Iceland
Nationwide data from Iceland are used as an example to study the effect are used as an example to study the effect of sales of antidepressants on suicide, of sales of antidepressants on suicide, disability, hospital admissions and outdisability, hospital admissions and outpatient visits. patient visits.
Results

Results Sales of antidepressants
Sales of antidepressants increased from 8.4 daily defined doses per increased from 8.4 daily defined doses per 1000 inhabitants per day in1975 to 72.7 in 1000 inhabitants per day in1975 to 72.7 in 2000, which is a user prevalence of 8.7% 2000, which is a user prevalence of 8.7% for the adult population. Suicide rates for the adult population. Suicide rates fluctuated during1950^2000 but did not fluctuated during1950^2000 but did not show any definite trend.Rates for outshow any definite trend.Rates for outpatient visits increased slightly over the patient visits increased slightly over the period1989^2000 and admission rates period1989^2000 and admission rates increased even more.The prevalence of increased even more.The prevalence of disability due to depressive and anxiety disability due to depressive and anxiety disorders has not decreased over the past disorders has not decreased over the past 25 years. 25 years.
Conclusions Conclusions The dramatic increase in
The dramatic increase in the sales of antidepressants has not had the sales of antidepressants has not had any marked impact on the selected public any marked impact on the selected public health measures.Obviously, better health measures.Obviously, better treatment for depressive disorders is still treatment for depressive disorders is still needed in order to reduce the burden needed in order to reduce the burden caused by them. caused by them.
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None. Major depressive disorder is the second Major depressive disorder is the second leading cause of disability-adjusted lifeleading cause of disability-adjusted lifeyears in developed regions of the world years in developed regions of the world (Murray & Lopez, 1996) and antidepres- (Murray & Lopez, 1996) and antidepressants, the third-ranking therapy class sants, the third-ranking therapy class worldwide, experienced an 18% sales worldwide, experienced an 18% sales growth in 2000, with North America being growth in 2000, with North America being the dominant market (IMS Health, 2002) . the dominant market (IMS Health, 2002) . However, the question remains: has this However, the question remains: has this had any impact on public health and the had any impact on public health and the burden of depression 
Data Data
The following nationwide data were The following nationwide data were collected from a range of official sources. collected from a range of official sources. Until 1993, very few children and Until 1993, very few children and adolescents under the age of 15 years were adolescents under the age of 15 years were prescribed antidepressants, and in that prescribed antidepressants, and in that same year only 0.8% of prescriptions were same year only 0.8% of prescriptions were issued to children under this age. According issued to children under this age. According to a recent limited prescription survey, to a recent limited prescription survey, 6.7% of the antidepressants were filled for 6.7% of the antidepressants were filled for this age group (Skyrsla, 1999) . Therefore this age group (Ský rsla, 1999) . Therefore a 1% annual increase was assumed and a 1% annual increase was assumed and deducted from the total quantities sold deducted from the total quantities sold when estimating the number of daily dewhen estimating the number of daily defined doses per 1000 inhabitants aged 15 fined doses per 1000 inhabitants aged 15 years or more during 1994-2000. years or more during 1994-2000. (Harvey, 1993) was used to analysis (Harvey, 1993) was used to estimate the length of such cycles. The estimate the length of such cycles. The model in Equation (1) assumes that the model in Equation (1) assumes that the expected count is proportional to a power expected count is proportional to a power of the population size. Thus, the parameter of the population size. Thus, the parameter 1 1 describes the trend structure of the series describes the trend structure of the series and and 0 0 is an intercept. The diagnostics of is an intercept. The diagnostics of the model were performed by analysing the model were performed by analysing the scaled residuals, the scaled residuals, , defined by Equation , defined by Equation (2): (2):
Statistical analysis Statistical analysis
The statistical inference was corrected for The statistical inference was corrected for eventual overdispersion, i.e. the variance eventual overdispersion, i.e. the variance being greater than the mean, by estimating being greater than the mean, by estimating a quasi-Poisson model of type (1). Eventual a quasi-Poisson model of type (1). Eventual misspecification of the model shows up in misspecification of the model shows up in the scaled residuals. An important omitted the scaled residuals. An important omitted variable should show association to them. variable should show association to them. The Ramsey-RESET test (Gujarati, 1995) The Ramsey-RESET test (Gujarati, 1995) was used to test the model specification, was used to test the model specification, such as functional form and eventual misssuch as functional form and eventual missing variables. ing variables. The possibility of autocorrelation was The possibility of autocorrelation was addressed by inclusion of autoregressive addressed by inclusion of autoregressive terms (Cameron & Trivedi, 1998) . The terms (Cameron & Trivedi, 1998) . The statistical program R was used for numerstatistical program R was used for numerical calculations (Ihaka & Gentleman, ical calculations (Ihaka & Gentleman, 1996) . 1996). The increase can be ascribed to new antiThe increase can be ascribed to new antidepressants, mainly SSRIs, that were introdepressants, mainly SSRIs, that were introduced to the market in Iceland by the end of duced to the market in Iceland by the end of 1988. During the period 1989-2000 the 1988. During the period 1989-2000 the total quantity of medication sold increased total quantity of medication sold increased by 48%, the quantity of antidepressants by 48%, the quantity of antidepressants increased by 388% and the quantity of increased by 388% and the quantity of other psychopharmacological medication, other psychopharmacological medication, mainly hypnotics, increased by 92%. The mainly hypnotics, increased by 92%. The cost of all medication calculated according cost of all medication calculated according to the consumer price index in the year to the consumer price index in the year 2000 increased by 66%, whereas in the 2000 increased by 66%, whereas in the same year the use of antidepressants same year the use of antidepressants reached 72.7 DDD/1000/day and the cost reached 72.7 DDD/1000/day and the cost had escalated by 461% since 1989 (Table  had escalated by 461% since 1989 (Table  1) . This is equivalent to an estimated user 1). This is equivalent to an estimated user point prevalence of 8.7% for the adult point prevalence of 8.7% for the adult population (aged 15 years or more) propopulation (aged 15 years or more) provided that all the patients are compliant in vided that all the patients are compliant in taking one defined dose per day. The sales taking one defined dose per day. The sales of antidepressants in Iceland increased of antidepressants in Iceland increased gradually from 1981, when tetracyclic antigradually from 1981, when tetracyclic antidepressants were introduced, up until 1985. depressants were introduced, up until 1985. Thereafter it remained relatively stable, at Thereafter it remained relatively stable, at around 15 DDD/1000/day, up until 1990; around 15 DDD/1000/day, up until 1990; since then it has increased very markedly, since then it has increased very markedly, mainly due to the addition of SSRIs to older mainly due to the addition of SSRIs to older antidepressants. The sales of tricyclic antiantidepressants. The sales of tricyclic antidepressants have been reduced gradually depressants have been reduced gradually by 21% to 8.6 DDD/1000/day in the year by 21% to 8.6 DDD/1000/day in the year 2000, whereas the sales of SSRIs have con-2000, whereas the sales of SSRIs have continued to escalate to 49.2 DDD/1000/day, tinued to escalate to 49.2 DDD/1000/day, as can be seen from Table 2 , which Equation (1) is given in Table 2 , which suggests that the number of suicides has suggests that the number of suicides has increased slightly more than the correincreased slightly more than the corresponding increase in population and, by sponding increase in population and, by spectral analysis, estimates of the autospectral analysis, estimates of the autoregressive parameters (0.45 and regressive parameters (0.45 and 7 70.33) 0.33) suggest a cycle of about 5-6 years. The data suggest a cycle of about 5-6 years. The data do not allow us to determine whether this is do not allow us to determine whether this is due to some events within a year or due to some events within a year or whether there are genuine cycles in the whether there are genuine cycles in the process. The standard errors in Table 2 process. The standard errors in Table 2 are corrected for overdispersion. Residual are corrected for overdispersion. Residual analysis showed that the process is remarkanalysis showed that the process is remarkably constant over a 50-year period. The ably constant over a 50-year period. The scaled residuals showed no autocorrelation scaled residuals showed no autocorrelation after including the two autoregressive terms after including the two autoregressive terms Fig. 1 Fig. 1 Suicide rates per 100 000 inhabitants (bars), sales of pure alcohol per capita in 1950^2000 (---Suicide rates per 100 000 inhabitants (bars), sales of pure alcohol per capita in 1950^2000 (------) and ---) and sales of antidepressants in daily defined doses/1000/day during 1975^2000: -sales of antidepressants in daily defined doses/1000/day during 1975^2000: -----* *---tricyclic antidepressants; ---tricyclic antidepressants;
RESULTS RESULTS
Sales of antidepressants Sales of antidepressants and suicides and suicides
in the model. A Ramsey-RESET test did not in the model. A Ramsey-RESET test did not indicate that the model was wrongly speciindicate that the model was wrongly specified ( fied (P P¼0.98). Consequently, there is no 0.98). Consequently, there is no indication that a trend or some simple funcindication that a trend or some simple function of time is missing from the model as an tion of time is missing from the model as an explanatory variable, particularly not the explanatory variable, particularly not the increased sales of antidepressants. increased sales of antidepressants. To illustrate this point, a graph of the To illustrate this point, a graph of the annual average sales of pure alcohol per annual average sales of pure alcohol per inhabitant is also shown in Fig. 2 . The inhabitant is also shown in Fig. 2 . The Ramsey-RESET test did not suggest that Ramsey-RESET test did not suggest that the model was wrongly specified. To illusthe model was wrongly specified. To illustrate this further the model was retrate this further the model was reestimated with alcohol consumption per estimated with alcohol consumption per capita and its lagged value added to the capita and its lagged value added to the model. The population in the year 2000 was about 283 000 and the average suicide rate about 283 000 and the average suicide rate was 11/100 000, so the expected annual was 11/100 000, so the expected annual number of suicides is around 30. The overnumber of suicides is around 30. The overdispersion coefficient in the model containdispersion coefficient in the model containing autoregressive terms is approximately ing autoregressive terms is approximately 1.5, therefore the standard deviation of 1.5, therefore the standard deviation of the yearly number of suicides is the square the yearly number of suicides is the square root of 1.5 root of 1.56 630, which is about 7. In a 30, which is about 7. In a model without autoregressive terms the model without autoregressive terms the overdispersion is about 1.9, which gives a overdispersion is about 1.9, which gives a standard deviation in the region of 8. Thus, standard deviation in the region of 8. Thus, the autoregressive parameters have limited the autoregressive parameters have limited impact on predicting the number of suicides. impact on predicting the number of suicides.
Sales of antidepressants Sales of antidepressants and psychiatric out-patient and psychiatric out-patient visits and hospital admissions visits and hospital admissions
In spite of the dramatic increase in the sales In spite of the dramatic increase in the sales of antidepressants, the rates of psychiatric of antidepressants, the rates of psychiatric out-patient consultations and in-patient out-patient consultations and in-patient treatment for depressive disorders increased treatment for depressive disorders increased (Fig. 3) . After correcting for the increase in (Fig. 3) . After correcting for the increase in the population aged 15 years or more, the the population aged 15 years or more, the number of patients admitted increased by number of patients admitted increased by about 3.9% annually. Similarly, after about 3.9% annually. Similarly, after correcting for the increase in population correcting for the increase in population the admission rates increased by 5.4% per the admission rates increased by 5.4% per year (i.e. each patient was admitted more year (i.e. each patient was admitted more often). Furthermore, the number of outoften). Furthermore, the number of outpatient consultations increased by 2% per patient consultations increased by 2% per year during the period 1989-2000. The year during the period 1989-2000. The total duration of in-patient treatment for total duration of in-patient treatment for depressive disorders per 100 inhabitants depressive disorders per 100 inhabitants decreased by 1.1% per year whereas that decreased by 1.1% per year whereas that for psychiatric disorders in general for psychiatric disorders in general decreased by 3.6% annually as the number decreased by 3.6% annually as the number of available beds decreased. of available beds decreased.
Disability Disability
The proportion of the general population The proportion of the general population claiming disability pension because of claiming disability pension because of depressive and anxiety disorders increased depressive and anxiety disorders increased from 0.4% to 0.7%, as it did for other from 0.4% to 0.7%, as it did for other disorders over the 25-year period of disorders over the 25-year period of 1976-2001; however, it remained similar 1976-2001; however, it remained similar as a proportion of all disability (i.e. about as a proportion of all disability (i.e. about 13%). 13%).
DISCUSSION DISCUSSION
The sales of antidepressants per capita in The sales of antidepressants per capita in Iceland in 2000 were probably comparable Iceland in 2000 were probably comparable to those in the USA (IMS Health, 2002) . to those in the USA (IMS Health, 2002) . The retail cost of antidepressants increased The retail cost of antidepressants increased in Iceland by 460% during the past 12 in Iceland by 460% during the past 12 Table 2  Table 2 Estimates of a quasi-Poisson model (Equation (1) psychiatric services by adults during1989^2000: psychiatric services by adults during1989^2000: & & patients admitted per10 000 inhabitants aged15 years or patients admitted per10 000 inhabitants aged15 years or more; more; total number of admissions per 10 000 inhabitants aged15 years or more; -total number of admissions per10 000 inhabitants aged15 years or more; ---X X ----in-patient days per --in-patient days per 100 inhabitants aged15 years or more; -100 inhabitants aged15 years or more; ---^--out-patient consultations per100 inhabitants aged15 years or more.
--out-patient consultations per100 inhabitants aged15 years or more. Helgason, 1990) . Depressive disorders Helgason, 1990) . Depressive disorders cause considerable impairment, result in cause considerable impairment, result in increased mortality, reduce the healthincreased mortality, reduce the healthrelated quality of life (Simon related quality of life (Simon et al et al, 1998) , 1998) and are costly for the patients, their families and are costly for the patients, their families and society. The direct cost of treating and society. The direct cost of treating depressive disorders in Iceland, the depressive disorders in Iceland, the population of which is approximately onepopulation of which is approximately onethousandth of that in the USA, was thousandth of that in the USA, was estimated to be equivalent to £18.6 million estimated to be equivalent to £18.6 million in (Skyrsla, 1999 ) and about 27% in 1998 (Ský rsla, 1999 and about 27% of this amount was ascribed to of this amount was ascribed to antidepressants, mainly SSRIs. antidepressants, mainly SSRIs.
The prevalence of subsyndromal deThe prevalence of subsyndromal depression or of depressive symptoms is conpression or of depressive symptoms is considerably higher than that of depressive siderably higher than that of depressive disorders, being 16-25% (Helgason, disorders, being 16-25% (Helgason, 1990) . Depressive disorders and symptoms 1990). Depressive disorders and symptoms are very common in primary care and are are very common in primary care and are often comorbid with physical disorders often comorbid with physical disorders (Kisely & Goldberg, 1996) ; they are also (Kisely & Goldberg, 1996) ; they are also mixed with anxiety disorders, for which mixed with anxiety disorders, for which antidepressants have been used increasingly antidepressants have been used increasingly in recent years. in recent years.
During the past 10-15 years new During the past 10-15 years new generations of antidepressants have been generations of antidepressants have been developed and marketed energetically. At developed and marketed energetically. At the same time, awareness campaigns have the same time, awareness campaigns have been launched to combat depression been launched to combat depression (Paykel (Paykel et al et al, 1998) and to prevent suicide , 1998) and to prevent suicide in a number of countries (Taylor in a number of countries (Taylor et al et al, , 1997) . In addition, guidelines for treating 1997). In addition, guidelines for treating depressive disorders have been issued depressive disorders have been issued (American Psychiatric Association, 2000) . (American Psychiatric Association, 2000) . These developments might have been These developments might have been expected to have a public health impact expected to have a public health impact by reducing disability, morbidity and by reducing disability, morbidity and mortality due to depressive disorders, even mortality due to depressive disorders, even more so as the new medications are simpler more so as the new medications are simpler to administer and more likely to be given in to administer and more likely to be given in adequate dosages than tricyclic antidepresadequate dosages than tricyclic antidepressants. However, the cost for society has sants. However, the cost for society has not been reduced and the impact on public not been reduced and the impact on public health is limited. health is limited.
Far fewer antidepressants are taken Far fewer antidepressants are taken than are sold (prescribed), therefore prevathan are sold (prescribed), therefore prevalence estimates based on sales data are too lence estimates based on sales data are too high due to limited compliance. In a recent high due to limited compliance. In a recent community survey the self-reported use of community survey the self-reported use of antidepressants (in DDD/1000/day) was antidepressants (in DDD/1000/day) was estimated to correspond to about 54% of estimated to correspond to about 54% of the official sales figures (Helgason the official sales figures (Helgason et al et al, , 2003) . The reasons for many of the pre-2003). The reasons for many of the prescriptions are not clear, as primary care scriptions are not clear, as primary care physicians have probably not diagnosed physicians have probably not diagnosed depressive disorder in more than 40-50% depressive disorder in more than 40-50% of patients prescribed antidepressants of patients prescribed antidepressants (Skyrsla, 1999; Ornstein (Ský rsla, 1999; Ornstein et al et al, 2000) . . It should be noted, however, that antidepresshould be noted, however, that antidepressants are being used increasingly for other sants are being used increasingly for other disorders, such as some anxiety disorders disorders, such as some anxiety disorders and chronic pain. and chronic pain.
Admissions, out-patient visits Admissions, out-patient visits and disability and disability Admission rates for in-patient treatment of Admission rates for in-patient treatment of depressive disorders have increased, partly depressive disorders have increased, partly because of more readmissions and partly because of more readmissions and partly because more patients are admitted. The because more patients are admitted. The number of in-patient days used for depresnumber of in-patient days used for depressive disorders has decreased insignificantly sive disorders has decreased insignificantly but in contrast, the decrease in in-patient but in contrast, the decrease in in-patient days for psychiatric disorders in general days for psychiatric disorders in general has been quite marked. At the same time has been quite marked. At the same time as these trends were occurring, the availas these trends were occurring, the availability of psychiatric hospital beds was also ability of psychiatric hospital beds was also decreasing. The increased annual admission decreasing. The increased annual admission rate may indicate increasing acceptance of rate may indicate increasing acceptance of treatment and decreasing stigmatisation, treatment and decreasing stigmatisation, as well as a possible lower admission as well as a possible lower admission threshold for depressive disorders because threshold for depressive disorders because beds for other disorders might have been beds for other disorders might have been freed up owing to the tendency to treat freed up owing to the tendency to treat people with psychosis in the community. people with psychosis in the community. The rates for psychiatric out-patient visits The rates for psychiatric out-patient visits increased, thus it is conceivable that the increased, thus it is conceivable that the new antidepressants have not stopped the new antidepressants have not stopped the need to refer intractable cases of depression need to refer intractable cases of depression for speciality treatment. It has been found for speciality treatment. It has been found in clinical studies that adequate treatment in clinical studies that adequate treatment can be expected to alleviate physical and can be expected to alleviate physical and psychosocial impairment in patients with psychosocial impairment in patients with depression and to improve their quality of depression and to improve their quality of life (Simon life (Simon et al et al, 1998) . Despite extensive , 1998) . Despite extensive pharmacological treatment, the prevalence pharmacological treatment, the prevalence rates for disability due to depressive and anrates for disability due to depressive and anxiety disorders increased, although not as a xiety disorders increased, although not as a proportion of total disability. It should be proportion of total disability. It should be noted that the increased prevalence of disnoted that the increased prevalence of disability pension between 1996 and 2001 is ability pension between 1996 and 2001 is related to changes in disability assessment. related to changes in disability assessment.
Suicide rates Suicide rates
Suicide rates in Iceland have fluctuated Suicide rates in Iceland have fluctuated roughly as an autoregressive Poisson roughly as an autoregressive Poisson process with a dispersion coefficient of 1.5 process with a dispersion coefficient of 1.5 during the latter half of the 20th century, during the latter half of the 20th century, remaining on average about 11/100 000. remaining on average about 11/100 000. The age and gender distribution of those The age and gender distribution of those who died by suicide may have changed durwho died by suicide may have changed during this period, but the overall rates have ing this period, but the overall rates have not been affected by the sales of antinot been affected by the sales of antidepressants, which have increased ninefold depressants, which have increased ninefold since 1975. It is unlikely, according to our since 1975. It is unlikely, according to our findings, that a reduction in the sales of findings, that a reduction in the sales of antidepressants would affect the rates of antidepressants would affect the rates of psychiatric service use and suicide. psychiatric service use and suicide.
Unemployment has not been a problem Unemployment has not been a problem in Iceland during the study period, with less in Iceland during the study period, with less than 1% of the labour force being out of than 1% of the labour force being out of work most of the time. However, in 1969 work most of the time. However, in 1969 unemployment rose to 2.5%, only to unemployment rose to 2.5%, only to decrease again and then rise to 5% in decrease again and then rise to 5% in 1995. In 1999 it had fallen once more to 1995. In 1999 it had fallen once more to less than 2%. One-third or less of those less than 2%. One-third or less of those unemployed were out of work for more unemployed were out of work for more than 6 months (Statistics Iceland, 2002) . than 6 months (Statistics Iceland, 2002) . The Ramsey-RESET test (Gujarati, 1995) The Ramsey-RESET test (Gujarati, 1995) does not indicate that unemployment and does not indicate that unemployment and other unknown variables have had an effect other unknown variables have had an effect on the number of deaths by suicide. on the number of deaths by suicide.
One of the main features of time series One of the main features of time series models is to filter out trends and cycles. It models is to filter out trends and cycles. It is conceivable that alcohol consumption, is conceivable that alcohol consumption, unemployment and other variables affect unemployment and other variables affect suicide rates. If that is the case, the residual suicide rates. If that is the case, the residual diagnostics indicate that they are already diagnostics indicate that they are already sufficiently included in the trend-and-cycle sufficiently included in the trend-and-cycle component of the model. Thus, it is not component of the model. Thus, it is not likely that a counteracting effect of alcohol likely that a counteracting effect of alcohol and antidepressants can be invoked as an and antidepressants can be invoked as an explanation for not finding any effect of explanation for not finding any effect of the huge increase in antidepressant use on the huge increase in antidepressant use on suicide rates in Iceland. suicide rates in Iceland.
Suicide rates in the population are a Suicide rates in the population are a very crude measure of the public health very crude measure of the public health 1997) , and in the , 1997), and in the USA (Maris, 2002) . However, it may be USA (Maris, 2002) . However, it may be noted that the suicide rate in Norway has noted that the suicide rate in Norway has remained unchanged at the 1980 level since remained unchanged at the 1980 level since 1995 (Retterstol 1995 (Retterstö l et al et al, 2002 , in spite of , 2002), in spite of increasing sales of antidepressants. The increasing sales of antidepressants. The results of a Swedish study suggested that results of a Swedish study suggested that the increasing use of antidepressants was a the increasing use of antidepressants was a contributing factor to the decreasing suicide contributing factor to the decreasing suicide rates (Isacsson, 2000) . The results of the rates (Isacsson, 2000) . The results of the present study do not support this suggespresent study do not support this suggestion because a hypothetical missing tion because a hypothetical missing explanatory variable (i.e. increased sales explanatory variable (i.e. increased sales of antidepressants) did not correlate with of antidepressants) did not correlate with the residuals of the statistical model used. the residuals of the statistical model used. Although clinical psychiatrists are conAlthough clinical psychiatrists are convinced that suicides can be prevented in vinced that suicides can be prevented in individual patients by adequate treatment, individual patients by adequate treatment, it has been difficult to prove in large studies it has been difficult to prove in large studies (Khan (Khan et al et al, 2000) . , 2000). It is of major importance to study the It is of major importance to study the effects of the extensive prescribing of antieffects of the extensive prescribing of antidepressants to the large number of people depressants to the large number of people obtaining them who do not have a diagobtaining them who do not have a diagnosed depressive disorder. Data on newer nosed depressive disorder. Data on newer pharmacotherapies for patients with subpharmacotherapies for patients with subsyndromal or mixed anxiety-depression syndromal or mixed anxiety-depression and for special populations such as children and for special populations such as children and adolescents are insufficient to guide and adolescents are insufficient to guide treatment decisions (Agency for Health treatment decisions (Agency for Health Care Policy and Research, 1999) . The reCare Policy and Research, 1999) . The results of such studies could help to elucidate sults of such studies could help to elucidate whether antidepressants improve the recipiwhether antidepressants improve the recipients' quality of life and/or prevent later deents' quality of life and/or prevent later development of major depression or other velopment of major depression or other impairment. impairment.
There are no signs that the rapidly There are no signs that the rapidly escalating use of antidepressants is reducing escalating use of antidepressants is reducing the burden of depressive disorders the burden of depressive disorders (Moncrieff, 2002) . The present study has (Moncrieff, 2002) . The present study has not revealed any marked impact of the not revealed any marked impact of the dramatic increase in sales of antidepresdramatic increase in sales of antidepressants on psychiatric aspects of public health sants on psychiatric aspects of public health at the macro-level, except bringing the most at the macro-level, except bringing the most common mental disorders into the maincommon mental disorders into the mainstream of medical treatment for the benefit stream of medical treatment for the benefit of patients, but at a substantial increase in of patients, but at a substantial increase in medication cost. This has possibly reduced medication cost. This has possibly reduced stigmatisation and brought about an stigmatisation and brought about an increased acceptance of the need for treatincreased acceptance of the need for treatment, as is reflected in the growing number ment, as is reflected in the growing number of patients admitted to hospital psychiatric of patients admitted to hospital psychiatric departments. But because the public health departments. But because the public health indicators studied are based on administraindicators studied are based on administrative data, more detailed studies on distress, tive data, more detailed studies on distress, quality of life, work performance and quality of life, work performance and short-term absenteeism might reveal a short-term absenteeism might reveal a greater impact (Simon greater impact (Simon et al et al, 1998) . , 1998). Recognition of patients who will benefit from treatment with antidepressant medication has to be improved. medication has to be improved. A diagnostic breakdown of out-patient consultations was not available, although it can be assumed that the majority were probably for depressive and anxiety disorders. can be assumed that the majority were probably for depressive and anxiety disorders. 
